CSNK1A1 E98突变重塑del(5q)骨髓增生异常肿瘤的信号与代谢
该研究整合转录组、磷酸化蛋白质组和激酶活性谱分析造血干/祖细胞,并结合体内连续移植实验,发现Csnk1a1 E98V是功能改变型而非功能缺失型突变。该突变抑制激酶信号网络并重编程代谢,导致细胞应激耐受但适应不良,并增加铁过载和铁死亡易感性。del(5q) MDS患者中CSNK1A1突变与血小板减少、骨髓原始细胞升高和骨髓铁降低相关。
要点
- Csnk1a1 E98V是功能改变型突变,不增强克隆扩增,但抑制激酶信号和翻译。
- 突变细胞代谢重编程为糖酵解增强、线粒体呼吸降低,应激耐受但适应不良。
- 突变细胞巨核生成受损,对铁过载和RSL-3诱导的铁死亡更敏感。
核心结论
- Csnk1a1 E98V是功能改变型突变,不增强克隆扩增,而是促进应激耐受并暴露代谢和铁依赖弱点。
研究设计与样本
- 研究整合转录组、磷酸化蛋白质组和激酶活性谱分析造血干/祖细胞,并结合体内连续移植实验。
主要发现
- Csnk1a1 E98V保留长期造血重建能力,不增强体内克隆扩增。
- 突变抑制激酶信号网络,协调抑制核糖体基因表达、蛋白质翻译和细胞周期程序。
- 代谢重编程表现为线粒体呼吸降低、糖酵解通量增加,且无法适应代谢挑战。
- 突变细胞巨核生成受损,对铁过载和RSL-3介导的铁死亡易感性增加。
- del(5q) MDS患者中CSNK1A1突变与血小板减少、骨髓原始细胞升高和骨髓铁降低相关。
临床怎么用
- del(5q) MDS中CSNK1A1突变提示应激耐受表型,可能对代谢和铁依赖靶向治疗敏感。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Deletion of chromosome 5q [del(5q)] is the most common cytogenetic abnormality in myelodysplastic neoplasms (MDS) and results in haploinsufficiency of multiple genes, including CSNK1A1. Recurrent CSNK1A1 mutations, predominantly affecting the E98 hotspot, occur almost exclusively in del(5q) MDS and are associated with adverse outcomes, yet their impact on CK1ɑ function remains unclear. Using integrated transcriptomic, (phospho)proteomic, and kinome activity profiling in hematopoietic stem and progenitor cells (HSPCs), combined with in vivo serial transplantation assays, we show that Csnk1a1 E98V represents a change-of-function rather than a loss-of-function mutation. Unlike Csnk1a1 haploinsufficiency, Csnk1a1 E98V preserves long-term hematopoietic reconstitution and does not enhance clonal expansion in vivo. Instead, the mutation induces suppression of kinase signaling networks, leading to coordinated repression of ribosomal gene expression, protein translation, and cell cycle programs. This signaling rewiring is accompanied by metabolic reprogramming characterized by reduced mitochondrial respiration, increased glycolytic flux, and an inability to adapt to metabolic challenges, creating a stress-tolerant but inflexible cellular state. Notably, Csnk1a1 E98V cells exhibit impaired megakaryopoiesis and increased vulnerability to iron overload, as well as RSL-3-mediated ferroptosis. Analysis of del(5q) MDS patients confirmed that CSNK1A1 mutations are associated with distinct clinical features, including thrombocytopenia, elevated myeloblasts, and reduced bone marrow iron levels. Together, our findings support a two-step model in which del(5q)-associated CSNK1A1 haploinsufficiency drives clonal expansion, followed by acquisition of CSNK1A1 mutations that promote stress tolerance rather than increased proliferation. This adaptive rewiring exposes metabolic and iron-dependent vulnerabilities that may be therapeutically exploited.
引用
- Schmitz S, Pearce JE, Martinez-Høyer S, et al. Csnk1a1 E98 mutations rewire signaling and metabolism in del(5q) myelodysplastic neoplasms. Leukemia. 2026. PMID: 42693162. doi:10.1038/s41375-026-03122-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。